Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral hyoscine for cervical ripening in term primiparous pregnancy
IRCT20180819040830N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2017
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of scopolamine in pregnancy (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Cervix status. Started Sep 2017; status: completed.
02
Drugs
scopolamine
03
Conditions
pregnancy
Beyond the preview
Go deeper on IRCT20180819040830N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180819040830N1.